“Whether it’s acquisition or delivering on corporate growth targets, I enjoy that Quorum designs strategy that is unique to our clients’ commercial and corporate goals. Reimbursement should not be an afterthought; it requires foresight and early-stage planning.”
Mr. Graham works with clients to identify and demonstrate the value of life science innovation to influence product adoption across key stakeholders. His group has been essential in helping many of our clients raise capital, achieve meaningful coverage and payment milestones, and attain commercial success. His expertise spans the entire product life cycle, from market research and strategy development to clinical study design and pricing. In particular, he has extensive experience in evaluating potential market opportunities through sizing and forecasting analytics; reviewing and designing clinical studies to incorporate payer-focused endpoints and support value-based payment; constructing comprehensive market access strategies for therapeutics and diagnostics across multiple settings of care; developing and executing economic and pricing studies; and conducting primary market research with providers and payers to identify and validate drivers of clinical and economic value.
Mr. Graham’s work spans several clinical specialties, including oncology, cardiology, orthopedics and ophthalmology. His work has also been featured in abstracts submitted to national and international organizations, such as the American Society of Cataract and Refractive Surgery (ASCRS) and International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Prior to joining Quorum Consulting, Mr. Graham was involved in several areas of the life sciences industry, including drug development, licensing, and M&A with companies such as BASi, Covidien, and ChinaBio, LLC.
Master of Bioscience, Claremont Colleges, Keck Graduate Institute of Applied Life Sciences
BS, Pre-Med Studies, Chemistry, Psychology, Ball State University